ArticleStatistics in medicine2022

TITE-BOIN12: A Bayesian phase I/II trial design to find the optimal biological dose with late-onset toxicity and efficacy.

Yanhong Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.